NCT00755885View on ClinicalTrials.gov

Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

June 4, 2016

Study Completion Date

June 4, 2016

Conditions
Breast Cancer
Interventions
DRUG

abiraterone acetate

OTHER

laboratory biomarker analysis

OTHER

pharmacogenomic studies

Trial Locations (6)

CF14 2TL

Velindre Cancer Centre, Whitchurch

SE1 9RT

Guy's Hospital, London

SM2 5PT

Royal Marsden - Surrey, Sutton

B15 2TT

University of Birmingham,, Birmingham

EH4 2XU

Western General Hospital, Edinburgh

G12 0YN

The Beatson West of Scotland Cancer Centre, Glasgow

Sponsors

Lead Sponsor

Cancer Research UK
All Listed Sponsors
lead

Cancer Research UK

OTHER